Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

…, JE Buhlmann, MF Tomczak, BH Horwitz… - European journal of …, 2003 - Wiley Online Library
Newer members of the B7‐CD28 superfamily include the receptor PD‐1 and its two ligands,
PD‐L1 and PD‐L2. Here, we characterize the expression of PD‐1, PD‐L1, and PD‐L2 in …

Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function

…, JR Mora, FJ Quintana, C Klein, AM Muise, BH Horwitz… - Immunity, 2014 - cell.com
Intact interleukin-10 receptor (IL-10R) signaling on effector and T regulatory (Treg) cells are
each independently required to maintain immune tolerance. Here we show that IL-10 …

[PDF][PDF] Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19

…, TO Robinson, AK Shalek, SC Glover, BH Horwitz… - Cell, 2021 - cell.com
SARS-CoV-2 infection can cause severe respiratory COVID-19. However, many individuals
present with isolated upper respiratory symptoms, suggesting potential to constrain viral …

Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment

E Alcamo, JP Mizgerd, BH Horwitz… - The Journal of …, 2001 - journals.aai.org
NF-κB binding sites are present in the promoter regions of many acute phase and inflammatory
response genes, suggesting that NF-κB plays an important role in the initiation of innate …

Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans

…, J Ouahed, A Biswas, JA Goettel, BH Horwitz… - Advances in …, 2014 - Elsevier
Interleukin 10 (IL10) is a key anti-inflammatory cytokine that can inhibit proinflammatory
responses of both innate and adaptive immune cells. An association between IL10 and intestinal …

CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice

…, AB Rogers, K Cormier, B Plank, BH Horwitz… - The American journal of …, 2003 - Elsevier
Inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, increase the
risk of colorectal cancer in humans. It has been recently shown in humans and animal …

Innate Immune Inflammatory Response against Enteric Bacteria Helicobacter hepaticus Induces Mammary Adenocarcinoma in Mice

…, PR Nambiar, C Boussahmain, YY Wang, BH Horwitz… - Cancer research, 2006 - AACR
Inflammation associated with bacterial infections is a risk factor for cancers in humans, yet
its role in breast cancer remains poorly understood. We have previously shown that innate …

Gastroenteritis in NF-κB-Deficient Mice Is Produced with Wild-Type Camplyobacter jejuni but Not with C. jejuni Lacking Cytolethal Distending Toxin despite …

…, Z Ge, NS Taylor, S Xu, BH Horwitz… - Infection and …, 2004 - Am Soc Microbiol
Campylobacter jejuni continues to be a leading cause of bacterial enteritis in humans.
However, because there are no readily available animal models to study the pathogenesis of C. …

CD4+CD25+ Regulatory Lymphocytes Require Interleukin 10 to Interrupt Colon Carcinogenesis in Mice

…, Z Ge, Y Feng, M Tomczak, AB Rogers, BH Horwitz… - Cancer research, 2003 - AACR
Roles for host immune response in carcinogenesis are not well defined. Recent studies have
shown that microbially driven inflammation can lead to colon cancer and that prior transfer …

[HTML][HTML] Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer

JG Fox, Z Ge, MT Whary, SE Erdman, BH Horwitz - Mucosal immunology, 2011 - Elsevier
Pioneering work in the 1990s first linked a novel microaerobic bacterium, Helicobacter
hepaticus, with chronic active hepatitis and inflammatory bowel disease in several murine models…